Vivani Medical posts new investor presentation

Q: What did Vivani Medical (VANI) announce in its August 17, 2026 Form 8-K?

Vivani Medical announced that it furnished an investor slide presentation under Item 7.01 (Regulation FD). The deck, dated August 17, 2026, provides business updates shared at industry and investor conferences.

Q: How is the Vivani Medical (VANI) slide presentation treated under securities laws?

Vivani states the slide presentation is being furnished, not filed, under Regulation FD. As a result, it is not subject to Section 18 liability and is only incorporated into other SEC filings if expressly referenced.

Q: Where is the Vivani Medical (VANI) investor presentation referenced in the Form 8-K?

The investor presentation is included as Exhibit 99.1 to the Form 8-K. It is described as the “Vivani Medical, Inc. slide presentation” dated August 17, 2026 and is furnished for informational purposes.

Q: Does Vivani Medical (VANI) commit to updating the August 17, 2026 slide presentation?

Vivani notes the slide presentation speaks only as of its date. The company may update it in the future but specifically disclaims any obligation to do so for subsequent events or circumstances.

Q: What exhibits are included with Vivani Medical’s (VANI) August 17, 2026 Form 8-K?

The Form 8-K includes Exhibit 99.1, the Vivani Medical investor slide presentation dated August 17, 2026, and Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.

Vivani Medical, Inc. filed a Form 8-K to furnish an investor slide presentation under Item 7.01 (Regulation FD Disclosure).

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Vivani Medical, Inc. filed a Form 8-K to furnish an investor slide presentation under Item 7.01 (Regulation FD Disclosure). The company states that it periodically presents and distributes these slides to the investment community at conferences to provide business updates.

The slide deck, titled “Vivani Medical, Inc. slide presentation” and dated August 17, 2026, is included as Exhibit 99.1. Vivani clarifies that this information is being furnished, not filed, so it is not subject to Section 18 liability and is not incorporated into Securities Act or Exchange Act filings unless expressly referenced.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Presentation Date: August 17, 2026 Investor Presentation Exhibit: 99.1 Cover Page Inline XBRL Exhibit: 104

3 metrics

Presentation Date August 17, 2026 Date of Vivani Medical, Inc. slide presentation furnished as Exhibit 99.1

Investor Presentation Exhibit 99.1 Exhibit number for Vivani Medical, Inc. slide presentation

Cover Page Inline XBRL Exhibit 104 Exhibit number for Cover Page Interactive Data File

Key Terms

Regulation FD, emerging growth company, incorporated by reference

3 terms

Regulation FD regulatory

"Item 7.01. Regulation FD Disclosure. Vivani Medical, Inc."

Regulation FD is a rule that prevents company insiders, like executives, from sharing important information with some people before others get it. It matters because it helps ensure all investors have equal access to key news, making the stock market fairer and reducing chances of insider trading.

emerging growth company regulatory

"Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

incorporated by reference regulatory

"shall not be incorporated by reference in any filing under the Securities Act"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Vivani Medical (VANI) announce in its August 17, 2026 Form 8-K?

Vivani Medical announced that it furnished an investor slide presentation under Item 7.01 (Regulation FD). The deck, dated August 17, 2026, provides business updates shared at industry and investor conferences.

How is the Vivani Medical (VANI) slide presentation treated under securities laws?

Vivani states the slide presentation is being furnished, not filed, under Regulation FD. As a result, it is not subject to Section 18 liability and is only incorporated into other SEC filings if expressly referenced.

Where is the Vivani Medical (VANI) investor presentation referenced in the Form 8-K?

The investor presentation is included as Exhibit 99.1 to the Form 8-K. It is described as the “Vivani Medical, Inc. slide presentation” dated August 17, 2026 and is furnished for informational purposes.

Does Vivani Medical (VANI) commit to updating the August 17, 2026 slide presentation?

Vivani notes the slide presentation speaks only as of its date. The company may update it in the future but specifically disclaims any obligation to do so for subsequent events or circumstances.

What exhibits are included with Vivani Medical’s (VANI) August 17, 2026 Form 8-K?

The Form 8-K includes Exhibit 99.1, the Vivani Medical investor slide presentation dated August 17, 2026, and Exhibit 104, the Cover Page Interactive Data File embedded within the Inline XBRL document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/17/2026 - 08:01 AM Accepted by SEC EDGAR 08/17/2026 - 08:00 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 17, 2026

Vivani Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-36747

02-0692322

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

1350 S. Loop Road Alameda, California	94502
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (415) 506-8462

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		VANI		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01. Regulation FD Disclosure.

Vivani Medical, Inc. (“Vivani”) from time to time presents, and/or distributes to the investment community at various industry and other conferences, slide presentations to provide updates and summaries of its business. A copy of these slides is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated by reference herein. The slide presentation speaks only as of the date of this Current Report on Form 8-K. While Vivani may elect to update the slide presentation in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Vivani specifically disclaims any obligation to do so.

The information contained in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), as amended, or otherwise subject to the liabilities under that Section. Furthermore, the information contained in this Item 7.01 and Exhibit 99.1 shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Vivani Medical, Inc. slide presentation dated August 17, 2026.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.